Insilico Medicine raises $255m in Series C | Eight Roads

Insilico Medicine, an AI-based platform for drug development and discovery, announced $255m in Series C financing.

分享

Related Articles

空间智能公司宸境科技获数千万美元融资，斯道资本联合领投

分钟阅读

Rulai Launches 'Low-Code' Chatbot and Raises $6.5m

分钟阅读

Launching a $275m Dedicated Tech Fund in China

分钟阅读

斯道资本委任赵峰博士担任投资合伙人

分钟阅读

隐私及法律条款